COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
15 hedge funds and large institutions have $77K invested in COSCIENS Biopharma Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
35% more capital invested
Capital invested by funds: $56.9K → $77K (+$20.2K)
0.2% more ownership
Funds ownership: 0.67% → 0.87% (+0.2%)
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$35.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.87K |
| 3 |
Morgan Stanley
New York
|
+$301 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$14.1K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$3.13K |
| 3 |
Citigroup
New York
|
-$2.42K |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$2.21K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$203 |
CSCI Hedge Fund Activity: Q1 2025 in Review
15 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q1 2025, worth a combined $77K — up 35% from $56.9K a quarter earlier.
Fund positioning in CSCI was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $35.1K. The largest seller was National Bank of Canada, cutting an estimated $14.1K.
- 15 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $77K of COSCIENS Biopharma Inc. Common Stock stock for Q1 2025, up 35% quarter-over-quarter.
- 2 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q1 2025 and 2 closed out, a net change of 0 holders.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q1 2025 was Susquehanna International Group, an estimated $35.1K added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q1 2025 was National Bank of Canada, an estimated $14.1K sold.
Based on aggregated 13F filings for Q1 2025.